Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

Symptom Severity, Mood, and Healthcare Use Are Associated With Satisfaction in Patients With Irritable Bowel Syndrome.

Singh P, Ballou S, Katon J, Takazawa E, Rangan V, Mukherjee R, Iturrino J, Nee J, Lembo A.

Clin Gastroenterol Hepatol. 2020 Feb 10. pii: S1542-3565(20)30170-1. doi: 10.1016/j.cgh.2020.01.045. [Epub ahead of print]

PMID:
32057975
2.

Microbiome and Its Role in Irritable Bowel Syndrome.

Pimentel M, Lembo A.

Dig Dis Sci. 2020 Feb 5. doi: 10.1007/s10620-020-06109-5. [Epub ahead of print] Review.

PMID:
32026278
3.

Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials.

Lembo AJ, Covington PS, Dove LS, Andrae DA.

Neurogastroenterol Motil. 2020 Jan 27:e13774. doi: 10.1111/nmo.13774. [Epub ahead of print]

PMID:
31984655
4.

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.

Naismith RT, Wundes A, Ziemssen T, Jasinska E, Freedman MS, Lembo AJ, Selmaj K, Bidollari I, Chen H, Hanna J, Leigh-Pemberton R, Lopez-Bresnahan M, Lyons J, Miller C, Rezendes D, Wolinsky JS; EVOLVE-MS-2 Study Group.

CNS Drugs. 2020 Feb;34(2):185-196. doi: 10.1007/s40263-020-00700-0.

PMID:
31953790
5.

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1).

Chey WD, Lembo AJ, Rosenbaum DP.

Am J Gastroenterol. 2020 Feb;115(2):281-293. doi: 10.14309/ajg.0000000000000516.

PMID:
31934897
6.

Can an Evidence-Based Approach Improve the Patient-Physician Relationship?

Cifu AS, Lembo A, Davis AM.

JAMA. 2020 Jan 7;323(1):31-32. doi: 10.1001/jama.2019.19427. No abstract available.

PMID:
31910263
7.

Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome.

Nee J, Salley K, Ludwig AG, Sommers T, Ballou S, Takazawa E, Duehren S, Singh P, Iturrino J, Katon J, Lee HN, Rangan V, Lembo AJ.

Clin Transl Gastroenterol. 2019 Dec;10(12):e00110. doi: 10.14309/ctg.0000000000000110.

8.

Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey.

Rangan V, Ballou S, Shin A, Camilleri M; Beth Israel Deaconess Medical Center GI Motility Working Group, Lembo A.

Gastroenterology. 2020 Feb;158(3):786-788.e1. doi: 10.1053/j.gastro.2019.10.036. Epub 2019 Nov 9. No abstract available.

PMID:
31711922
9.

Placebo Response in Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.

Nee J, Sugarman MA, Ballou S, Katon J, Rangan V, Singh P, Zubiago J, Kaptchuk TJ, Lembo A.

Am J Gastroenterol. 2019 Dec;114(12):1838-1846. doi: 10.14309/ajg.0000000000000399.

PMID:
31592782
10.

VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS.

Pichi F, Neri P, Agarwal A, Invernizzi A, Choudhry N, Amer R, Lembo A, Nucci P, Thompson I, Sen HN, Shields CL.

Retina. 2019 Oct 1. doi: 10.1097/IAE.0000000000002656. [Epub ahead of print]

PMID:
31584561
11.

Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome.

Shin A, Ballou S, Camilleri M, Xu H, Lembo A.

Clin Gastroenterol Hepatol. 2019 Sep 20. pii: S1542-3565(19)31026-2. doi: 10.1016/j.cgh.2019.09.020. [Epub ahead of print]

PMID:
31546055
12.

Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey.

Ballou S, Singh P, Rangan V, Iturrino J, Nee J, Lembo A.

Aliment Pharmacol Ther. 2019 Nov;50(9):1019-1024. doi: 10.1111/apt.15500. Epub 2019 Sep 18.

PMID:
31532005
13.

Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea.

Singh P, Lee HN, Rangan V, Ballou S, Lembo J, Katon J, McMahon C, Friedlander D, Iturrino J, Nee J, Lembo A.

Clin Gastroenterol Hepatol. 2020 Feb;18(2):399-405.e1. doi: 10.1016/j.cgh.2019.08.020. Epub 2019 Aug 20.

PMID:
31442602
14.

Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey.

Ballou S, McMahon C, Lee HN, Katon J, Shin A, Rangan V, Singh P, Nee J, Camilleri M, Lembo A, Iturrino J.

Clin Gastroenterol Hepatol. 2019 Nov;17(12):2471-2478.e3. doi: 10.1016/j.cgh.2019.08.016. Epub 2019 Aug 13.

PMID:
31419572
15.

The international anorectal physiology working group (IAPWG) recommendations: Standardized testing protocol and the London classification for disorders of anorectal function.

Carrington EV, Heinrich H, Knowles CH, Fox M, Rao S, Altomare DF, Bharucha AE, Burgell R, Chey WD, Chiarioni G, Dinning P, Emmanuel A, Farouk R, Felt-Bersma RJF, Jung KW, Lembo A, Malcolm A, Mittal RK, Mion F, Myung SJ, O'Connell PR, Pehl C, Remes-Troche JM, Reveille RM, Vaizey CJ, Vitton V, Whitehead WE, Wong RK, Scott SM; All members of the International Anorectal Physiology Working Group.

Neurogastroenterol Motil. 2020 Jan;32(1):e13679. doi: 10.1111/nmo.13679. Epub 2019 Aug 12.

16.

A comparison of Icare PRO and Perkins tonometers in anesthetized children.

Serafino M, Villani E, Lembo A, Rabbiolo G, Specchia C, Trivedi RH, Nucci P.

Int Ophthalmol. 2020 Jan;40(1):19-29. doi: 10.1007/s10792-019-01143-3. Epub 2019 Jul 16.

PMID:
31313069
17.

Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation.

Singh P, Duehren S, Katon J, Rangan V, Ballou S, Patel R, Iturrino J, Lembo A, Nee J.

J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001239. [Epub ahead of print]

PMID:
31306344
18.

Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.

Singh P, Silvester J, Chen X, Xu H, Sawhney V, Rangan V, Iturrino J, Nee J, Duerksen DR, Lembo A.

United European Gastroenterol J. 2019 Jun;7(5):709-715. doi: 10.1177/2050640619826419. Epub 2019 Jan 19.

19.

Safety of Endoscopy in Heritable Connective Tissue Disorders.

Kilaru SM, Mukamal KJ, Nee JW, Oza SS, Lembo AJ, Wolf JL.

Am J Gastroenterol. 2019 Aug;114(8):1343-1345. doi: 10.14309/ajg.0000000000000189.

PMID:
31185005
20.

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.

Lacy BE, Harris LA, Chang L, Lucak S, Gutman C, Dove LS, Covington PS, Lembo A.

Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841290. doi: 10.1177/1756284819841290. eCollection 2019.

21.

Chronic Diarrhea and Constipation Are More Common in Depressed Individuals.

Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, Iturrino J, Lembo A, Nee J.

Clin Gastroenterol Hepatol. 2019 Dec;17(13):2696-2703. doi: 10.1016/j.cgh.2019.03.046. Epub 2019 Apr 4.

PMID:
30954714
22.

Oculofacial alterations in NBAS-SOPH like mutations: Case report.

Nucci F, Lembo A, Farronato M, Farronato G, Nucci P, Serafino M.

Eur J Ophthalmol. 2019 Mar 8:1120672119836335. doi: 10.1177/1120672119836335. [Epub ahead of print]

23.

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.

Nee JW, Johnston JM, Shea EP, Walls CE, Tripp K, Shiff S, Fox SM, Bochenek W, Weissman D, Currie MG, Lembo AJ.

Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):397-406. doi: 10.1080/17474124.2019.1575203. Epub 2019 Feb 18.

PMID:
30791771
24.

Fecal urgency is common in constipated patients and is associated with anxiety.

Singh P, Takazawa E, Rangan V, Ballou S, Katon J, McMahon C, Lee HN, Iturrino J, Nee J, Lembo A.

Neurogastroenterol Motil. 2019 Apr;31(4):e13545. doi: 10.1111/nmo.13545. Epub 2019 Feb 3.

PMID:
30714267
25.

Prevalence of Functional GI Diseases and Pelvic Floor Symptoms in Marfan Syndrome and Ehlers-Danlos Syndrome: A National Cohort Study.

Nee J, Kilaru S, Kelley J, Oza SS, Hirsch W, Ballou S, Lembo A, Wolf J.

J Clin Gastroenterol. 2019 Oct;53(9):653-659. doi: 10.1097/MCG.0000000000001173.

PMID:
30672816
26.

Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia.

Singh P, Seo Y, Ballou S, Ludwig A, Hirsch W, Rangan V, Iturrino J, Lembo A, Nee JW.

J Neurogastroenterol Motil. 2019 Jan 31;25(1):129-136. doi: 10.5056/jnm17139.

27.

Clinical and manometric characteristics of women with paradoxical puborectalis syndrome.

Rangan V, Zakari M, Hirsch W, Ballou S, Singh P, Sommers T, Iturrino J, Nee J, Staller K, Lembo A.

United European Gastroenterol J. 2018 Dec;6(10):1578-1585. doi: 10.1177/2050640618798227. Epub 2018 Sep 3.

28.

Significant Morbidity and Mortality Associated with Fecal Impaction in Patients Who Present to the Emergency Department.

Sommers T, Petersen T, Singh P, Rangan V, Hirsch W, Katon J, Ballou S, Cheng V, Friedlander D, Nee J, Lembo A, Iturrino J.

Dig Dis Sci. 2019 May;64(5):1320-1327. doi: 10.1007/s10620-018-5394-8. Epub 2018 Dec 8.

PMID:
30535766
29.

Choroidal biomarkers.

Pichi F, Aggarwal K, Neri P, Salvetti P, Lembo A, Nucci P, Gemmy Cheung CM, Gupta V.

Indian J Ophthalmol. 2018 Dec;66(12):1716-1726. doi: 10.4103/ijo.IJO_893_18. Review.

30.

Prevalence of Chronic Constipation and Chronic Diarrhea in Diabetic Individuals in the United States.

Sommers T, Mitsuhashi S, Singh P, Hirsch W, Katon J, Ballou S, Rangan V, Cheng V, Friedlander D, Iturrino J, Lembo A, Nee J.

Am J Gastroenterol. 2019 Jan;114(1):135-142. doi: 10.1038/s41395-018-0418-8.

PMID:
30410038
31.

Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.

Vagge A, Ferro Desideri L, Nucci P, Serafino M, Giannaccare G, Lembo A, Traverso CE.

Diseases. 2018 Oct 22;6(4). pii: E96. doi: 10.3390/diseases6040096. Review.

32.

The Prevalence of Gastroesophageal Reflux in Patients With Excessive Central Airway Collapse.

Majid A, Kheir F, Alape D, Kent M, Lembo A, Rangan VV, Carreiro M, Gangadharan SP.

Chest. 2019 Mar;155(3):540-545. doi: 10.1016/j.chest.2018.09.021. Epub 2018 Oct 9.

33.

Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy.

Pichi F, Fragiotta S, Freund KB, Au A, Lembo A, Nucci P, Sebastiani S, Gutierrez Hernandez JC, Interlandi E, Pellegrini F, Dolz-Marco R, Gallego-Pinazo R, Orellana-Rios J, Adatia FA, Munro M, Abboud EB, Ghazi N, Cunha Souza E, Amer R, Neri P, Sarraf D.

Br J Ophthalmol. 2019 Aug;103(8):1137-1145. doi: 10.1136/bjophthalmol-2018-312774. Epub 2018 Sep 26.

PMID:
30257961
34.

Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic.

Ballou S, Alhassan E, Hon E, Lembo C, Rangan V, Singh P, Hirsch W, Sommers T, Iturrino J, Nee J, Lembo A.

Dig Dis Sci. 2018 Nov;63(11):2983-2991. doi: 10.1007/s10620-018-5237-7. Epub 2018 Aug 9.

PMID:
30094624
35.

Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome.

Huang CY, Daniels R, Lembo A, Hartog C, O'Brien J, Heymann T, Reinhart K, Nguyen HB; Sepsis Survivors Engagement Project (SSEP).

Int J Qual Health Care. 2019 Apr 1;31(3):191-198. doi: 10.1093/intqhc/mzy137.

PMID:
29924325
36.

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.

Fodor AA, Pimentel M, Chey WD, Lembo A, Golden PL, Israel RJ, Carroll IM.

Gut Microbes. 2019;10(1):22-33. doi: 10.1080/19490976.2018.1460013. Epub 2018 Jul 18.

37.

Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract.

Nee J, Rangan V, Lembo A.

Neurogastroenterol Motil. 2018 May;30(5):e13367. doi: 10.1111/nmo.13367. Review.

PMID:
29700963
38.

Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.

Ballou S, Beath A, Kaptchuk TJ, Hirsch W, Sommers T, Nee J, Iturrino J, Rangan V, Singh P, Jones M, Lembo A.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1738-1744.e1. doi: 10.1016/j.cgh.2018.04.009. Epub 2018 Apr 12.

39.

Early metabolic response to acute myocardial ischaemia in patients undergoing elective coronary angioplasty.

Di Marino S, Viceconte N, Lembo A, Summa V, Tanzilli G, Raparelli V, Truscelli G, Mangieri E, Gaudio C, Cicero DO.

Open Heart. 2018 Mar 10;5(1):e000709. doi: 10.1136/openhrt-2017-000709. eCollection 2018.

40.

Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States.

Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V, Iturrino-Moreda J, Friedlander D, Nee J, Lembo A.

Am J Gastroenterol. 2018 Apr;113(4):593-600. doi: 10.1038/ajg.2018.24. Epub 2018 Mar 6.

PMID:
29610515
41.

Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey.

Rangan V, Mitsuhashi S, Singh P, Ballou S, Hirsch W, Sommers T, Nee J, Iturrino J, Lembo A.

Clin Gastroenterol Hepatol. 2018 Sep;16(9):1450-1458.e2. doi: 10.1016/j.cgh.2018.02.020. Epub 2018 Feb 21.

42.

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Ballou S, Hirsch W, Singh P, Rangan V, Nee J, Iturrino J, Sommers T, Zubiago J, Sengupta N, Bollom A, Jones M, Moss AC, Flier SN, Cheifetz AS, Lembo A.

Aliment Pharmacol Ther. 2018 Apr;47(7):913-921. doi: 10.1111/apt.14551. Epub 2018 Feb 7.

43.

Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.

Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1569-1584.e2. doi: 10.1016/j.cgh.2018.01.021. Epub 2018 Jan 31.

PMID:
29374616
44.

Accommodative esotropia: the state of the art.

Lembo A, Serafino M, Strologo MD, Saunders RA, Trivedi RH, Villani E, Nucci P.

Int Ophthalmol. 2019 Feb;39(2):497-505. doi: 10.1007/s10792-018-0821-6. Epub 2018 Jan 13. Review.

PMID:
29332227
45.

Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013.

Hirsch W, Nee J, Ballou S, Petersen T, Friedlander D, Lee HN, Cheng V, Lembo A.

J Clin Gastroenterol. 2019 Feb;53(2):109-113. doi: 10.1097/MCG.0000000000000972.

46.

Chronic constipation.

Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simrén M, Lembo A, Young-Fadok TM, Chang L.

Nat Rev Dis Primers. 2017 Dec 14;3:17095. doi: 10.1038/nrdp.2017.95. Review.

PMID:
29239347
47.

Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.

Bollom A, Austrie J, Hirsch W, Nee J, Friedlander D, Iturrino J, Ballou S, Lembo A.

J Clin Gastroenterol. 2018 Oct;52(9):778-783. doi: 10.1097/MCG.0000000000000944.

48.

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Schoenfeld P, Lacy BE, Chey WD, Lembo AJ, Kurtz CB, Reasner DS, Bochenek W, Tripp K, Currie MG, Fox SM, Blakesley RE, OʼDea CR, Omniewski ND, Hall ML.

Am J Gastroenterol. 2018 Jan;113(1):105-114. doi: 10.1038/ajg.2017.230. Epub 2017 Aug 22.

49.

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.

Cash BD, Pimentel M, Rao SSC, Weinstock L, Chang L, Heimanson Z, Lembo A.

Therap Adv Gastroenterol. 2017 Sep;10(9):689-699. doi: 10.1177/1756283X17726087. Epub 2017 Sep 11.

50.

Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.

Delgado-Herrera L, Lasch K, Zeiher B, Lembo AJ, Drossman DA, Banderas B, Rosa K, Lademacher C, Arbuckle R.

Therap Adv Gastroenterol. 2017 Sep;10(9):673-687. doi: 10.1177/1756283X17726018. Epub 2017 Aug 24.

Supplemental Content

Support Center